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The Lysosomal Associated Membrane Protein type-2 (LAMP-2) is an abundant lysosomal membrane protein with an
important role in immunity, macroautophagy (MA) and chaperone-mediated autophagy (CMA). Mutations within
the Lamp2 gene cause Danon disease, an X-linked lysosomal storage disorder characterized by (cardio)myopathy
and intellectual dysfunction. The pathological hallmark of this disease is an accumulation of glycogen and autophagic
vacuoles in cardiac and skeletal muscle that, along with the myopathy, is also present in LAMP-2-deficient mice.
Intellectual dysfunction observed in the human disease suggests a pivotal role of LAMP-2 within brain. LAMP-2A, one
specific LAMP-2 isoform, was proposed to be important for the lysosomal degradation of selective proteins involved in
neurodegenerative diseases such as Huntington’s and Parkinson’s disease.
To elucidate the neuronal function of LAMP-2 we analyzed knockout mice for neuropathological changes, MA and
steady-state levels of CMA substrates. The absence of LAMP-2 in murine brain led to inflammation and abnormal
behavior, including motor deficits and impaired learning. The latter abnormality points to hippocampal dysfunction
caused by altered lysosomal activity, distinct accumulation of p62-positive aggregates, autophagic vacuoles and lipid
storage within hippocampal neurons and their presynaptic terminals. The absence of LAMP-2 did not apparently affect
MA or steady-state levels of selected CMA substrates in brain or neuroblastoma cells under physiological and prolonged
starvation conditions.
Our data contribute to the understanding of intellectual dysfunction observed in Danon disease patients and highlight
the role of LAMP-2 within the central nervous system, particularly the hippocampus.
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The Lysosomal Associated Membrane Protein type-2
(LAMP-2) is a heavily glycosylated protein that, along
with LAMP-1, constitutes the majority of all membrane
proteins in the lysosome. The carbohydrates of the
LAMP proteins form a glycocalyx lining the inner leaflet
of the lysosomal membrane that has a compact ap-
pearance of only 8 nm in thickness [1,2]. It is sug-
gested to maintain the structural integrity of the lysosomal* Correspondence: jblanz@biochem.uni-kiel.de
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unless otherwise stated.membrane. However, deglycosylation of the LAMP pro-
teins reduces their stability but does not affect lysosomal
integrity and its degradation capacity [3]. LAMP-2, most
likely in concert with LAMP-1, has been proposed to con-
tribute to the maturation of autophagic vacuoles [4,5] and
phagosomes [6-8] by promoting vesicular fusion events
along microtubules [8] and is also involved in endosomal/
lysosomal cholesterol trafficking [9,10].
Alternative splicing of the Lamp2 gene produces three
isoforms, namely LAMP-2A, LAMP-2B and LAMP-2C
that are expressed in a tissue specific manner [11-13].
One particular function of the isoform LAMP-2A is to fa-
cilitate the selective import and degradation of cytosolicl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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tophagy (CMA) [14,15] through recognition of a CMA-
targeting motif, a pentapeptide sequence biochemically
related to KFERQ present within 25–30% of all cytosolic
proteins [16].
This isoform is also implicated in major histocompati-
bility complex class II presentation of cytoplasmic anti-
gens [17] as well as in the regulation of T-cell responses
[18]. LAMP-2A is also the rate-limiting factor for the
neuronal uptake and degradation of aggregation prone
proteins via CMA such as α-synuclein (α-syn) [19,20]
and huntingtin (Htt) [21,22] that are neurotoxic when
aggregated [23,24]. Mutations within the Lamp2 gene
cause Danon disease, an X-linked “lysosomal glycogen
storage disease with normal acid maltase”. Danon dis-
ease patients suffer from severe skeletal and cardiac
myopathy as well as intellectual dysfunction [25-27].
Interestingly, one Danon disease patient was identified
to carry a mutation only affecting LAMP-2B, underlining
the importance of this specific isoform [26].
In addition to increased mortality up to post-natal day
40 and reduced size, we have previously described (car-
dio)myopathy and the pronounced accumulation of
autophagic vesicles in cardiac and skeletal muscle of
LAMP-2 knockout mice [4,28] similar to those reported
in human patients [26]. Neuropathological changes in
post-mortem material from a Danon disease patient have
been observed [29] which warranted a more in-depth
analysis of LAMP-2-deficient murine brain for the pres-
ence of neuropathological signs.
Here, we report that absence of LAMP-2 in mice leads
to inflammatory changes and lysosomal accumulation of
electron dense material within neurons of the central
nervous system (CNS). Behavioral abnormalities such as
impaired memory point to hippocampal dysfunction
caused by perturbed lysosomal activity, accumulation of
p62-positive aggregates as well as cholesterol storage
within neurons of the hippocampus. In addition, hippo-
campal neurons displayed a distinct accumulation of
lipofuscin and autophagic vacuoles containing amorph-
ous and multilamellar material. Despite its proposed role
for the lysosomal degradation of α-syn, Htt, the myocyte-
specific enhancer factor-2D (MEF2D) and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) in lysosomes via
CMA, steady-state levels of these proteins were unchanged
in LAMP-2-deficient brain tissue and in neuroblastoma
cells where LAMP-2 was stably down-regulated. Our data
demonstrate an essential role of the LAMP-2 protein
within the CNS for cognitive functions and autophagy.
Materials and methods
Experimental animals
LAMP-2-deficient mice were described previously [4,30].
Only male animals were used in this study due to theX-chromosomal location of the Lamp2 gene. Therefore,
LAMP-2-deficient animals that were backcrossed into
C57/BL6-N (Charles River) are referred to as LAMP-
2-/y. Animals were maintained in a conventional animal
facility. All procedures performed in this study involv-
ing animals were in accordance with the ethical stan-
dards set by the National Animal Care Committee of
Germany.
Materials
Substrates for activity assays (p-nitrophenyl-α-D-glucu-
ronide and p-nitrophenyl-N-acetyl-β-D-glucosiminide)
and filipin complex from Streptomyces filipinensis were
purchased from Sigma Aldrich (Steinheim, Germany).
Reagents for molecular biology and protein standards
were obtained from Fermentas (St. Leon-Rot, Germany).
Chemicals for buffers and RNA isolation were from Roth
(Karlsruhe, Germany) and the BCA protein assay kit and
Western blotting reagents from Pierce (Rockford, USA)
and Amersham (Little Chalfont, United Kingdom), re-
spectively. Complete® protease inhibitor and PefaBloc®
were purchased from Roche (Mannheim, Germany).
Media for common cell culture was acquired from PAA
(Pasching, Austria).
(Immuno)histology, filipin staining and electron
microscopy
For antibody labelling, mice were perfused transcardially
with 4% paraformaldehyde (PFA) in 0.1 M phosphate
buffer (PB). The brains were dissected and post-fixed for
4 hours. Thereafter, they were embedded in paraffin or
incubated in 30% sucrose/0.1 M PB. Five μm paraffin
sections or 35 μm free-floating cryosections were cut.
3,3’-Diaminobenzidine (DAB) staining was carried out
on free-floating cryosections using the ABC kit followed
by the Elite DAB staining kit according to the manufac-
turer’s instructions (Vector Laboratories, Enzo Life Sci-
ences, Lörrach, Germany). Periodic-Acid-Schiff (PAS)
staining was carried out according to common lab proto-
cols. TUNEL staining was performed using the ApopTag®
peroxidase in situ apoptosis detection kit (Millipore,
Schwalbach, Germany) according to the manufacturer´s
instructions. Sections were mounted in Eukitt (Sigma
Aldrich, Steinheim, Germany) and visualized using a BX50
microscope (Olympus, Hamburg, Germany). Filipin histo-
chemistry was performed on 35 μm vibratome sections at
room temperature. Sections were washed 2 × 10 minutes
in phosphate buffered saline (PBS), 2 × 10 minutes in 0.2%
saponin/PBS and then incubated in filipin (0.05 mg/ml)
for 20 minutes. After washing 2 × 10 minutes in 0.02%
saponin/PBS and 2 × 10 minutes in PBS, sections were
mounted in Prolong anti-fade mounting solution (Invitro-
gen, Darmstadt, Germany) and stored at 4°C. For electron
microscopy (EM) mice were perfused and post-fixed with
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sected and stored in fresh EM fixative at 4°C until further
treatment. Following osmication with 1% osmiumtetroxide
in cacodylate buffer the sections were dehydrated using
ascending alcohol concentration steps, followed by two
rinses in propylene oxide. Infiltration of the embedding
medium was performed by immersing the pieces in a 1:1
mixture of propylene oxide and Epon (Carl Roth GmbH &
Co. KG, Karlsruhe, Germany) and finally in neat Epon be-
fore hardening at 60°C for 48 hours. Semithin sections
(0.5 μm) were prepared for light microscopy, mounted on
glass slides and stained for 1 minute with 1% toluidine
blue. Ultrathin sections (60 nm) were cut and mounted on
copper grids. Sections were stained using uranyl acetate
and lead citrate. Thin sections were examined and photo-
graphed using an EM902 (Zeiss, Jena Germany) electron
microscope equipped with a Megaview III digital camera
(Albert Tröndle, Moorenweis, Germany).
LAMP-2 knockdown in N2a cells
Oligonucleotides were purchased from Sigma Aldrich
(Steinheim, Germany) and siRNA sequences were deter-
mined using the DSIR program (http://biodev.extra.cea.
fr/DSIR/DSIR.html). The corresponding scramble RNA
sequence was created using siRNA wizard (www.sirnawizard.
com/scrambled.php). Oligonucleotide sequences used were
as follows: forward primer LAMP-2 shRNA 5’-3’ [gatcccc
GGAGATGAATTTCACAATAttcaagagaTATGTGAAAT
TCATCTCCttttta], reverse primer LAMP-2 shRNA 5’-3’
[agcttaaaaaGGAGATGAATTTCACAATAtctcttgaaTAT
TGTGAAATTCATCTCCggg], forward primer scmbl
shRNA 5’-3’ [gatccccGATTGCTAAGACAAGTAAttcaaga
gaTTACTTGTCTATAGCAATCttttta], reverse primer
scmbl shRNA 5’-3’ [agcttaaaaaGATTGCTATAGACAAG
TAAtctcttgaaTTACTTGTCTATAGCAATCggg]. Short hair-
pin sequences were transferred between the BglII und
HindIII sites in the pSUPER vector (OligoEngine, Seattle,
USA) according to the manufacturer’s instructions. Mouse
neuroblastoma cells (N2a) were transfected using poly-
ethylenimine [31]. Stable transfection with G418 (PAA,
Pasching, Austria) was initiated 48 hours post-transfection
at a concentration of 100 μg/ml and increased by 100 μg/
ml every 48 hours until a maximum of 400 μg/ml G418
was reached. Cells were maintained for at least 2 weeks in
stable media before preparation for immunoblotting. Cells
were harvested in ice cold PBS with protease inhibitors
(complete® from Roche, Mannheim, Germany). Messenger
RNA was isolated from HeLa cells using the NucleoSpin®
RNAII kit (Macherey-Nagel, Düren, Germany) according
to the manufacturer’s instructions. Subsequently, LAMP-2A
was cloned in to the pcDNA3.1 Hygro+ vector (Invitrogen,
Darmstadt, Germany) from cDNA transcribed using the
RevertAid cDNA synthesis Kit (Fermentas, St. Leon-Rot,
Germany).Behavioral study
LAMP-2 knockout mice and wild-type controls (both:
n = 4) were examined in a battery of behavioral tests to
assess functional consequences of LAMP-2 deficiency.
Different tests of motor performance were included.
Home cage activity was analyzed in 20 cm vs 30 cm
transparent cages which were placed between 3 infrared
beams. Total number of beam crossings was recorded
for 23 hours during 30 minute intervals (start 4 pm).
Grip strength was measured using a T-shaped bar con-
nected to a digital dynamometer (Ugo Basile, Comerio,
Italy). Mice were placed in such a way that they grabbed
the bar spontaneously and were softly pulled backwards
by the tail until they released their grip. Ten such read-
outs were recorded. Motor coordination and equilib-
rium were tested using an accelerating rotarod (MED
Associates Inc., St. Albans, Vermont, USA). Mice were
first trained to maintain balance for 2 minutes at a con-
stant speed of 4 rpm. This training trial was followed by
four test trials, during which the rod accelerated from 4
to 40 rpm in 5 minutes. Consecutive trials were sepa-
rated by a 10 minute intertrial interval. Latency to fall-
ing off the rod was recorded up to 5 minutes. In the
swim test, mice were placed in a circular pool (diameter
150 cm; water temperature 26°C) for 30 seconds. The
animals were tracked using Ethovision tracking equipment
and software (Noldus Bv, Wageningen, The Netherlands)
for assessment of swimming velocity. Gait analysis was
performed while mice were ventrally video-tracked on a
transparent treadmill belt (Digigait, MouseSpecifics Inc,
MA, USA). Following brief habituation to the apparatus,
mice were tested at a constant belt speed of 16 cm/s. Dif-
ferent parameters were extracted from these video data
using Digigait analysis software: base-widths (distance be-
tween contralateral paws), stride lengths (distance between
subsequent placements of the same paw) and maximal
paw area (peak stance). As an indicator of emotional func-
tion, an exploration test was performed in a plexiglass
arena (42 cm× 26 cm × 30 cm) which mice could freely
explore for 5 minutes. Mice were video-tracked with
ANY-maze™ Video Tracking System software (Stoelting
Co., IL, USA). Total distance travelled was calculated as a
measure of exploratory activity. Finally, mice completed
different learning and memory tasks. Working memory
was assessed in a Y-maze consisting of 3 arms (5 cm wide,
30 cm long and enclosed by 30 cm high wall made of grey
plastic) [32]. Mice were placed in the center for 10 minutes
exploration of all arms. Locomotion was observed by a
webcam connected to a screen. Entries into all arms were
noted and an alternation was counted if an animal entered
three different arms consecutively. Percentage spontan-
eous alternation was calculated according to following for-
mula: [(number of alternations)/(total number of arm
entries – 2)]* 100. Contextual and cued fear conditioning
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18 cm high), containing a grid floor to deliver an electric
shock using a constant current shocker (MED Associates
Inc., St. Albans, Vermont, USA). The test set-up was
placed inside a sound attenuated chamber. On the first
day of the experiment, animals were placed in the testing
chamber and allowed to acclimate for 5 minutes. On the
second day, animals were again placed in the testing
chamber and after 2 minutes of exploration (baseline
score), a buzzer was sounded for 30 seconds. This auditory
stimulus, the conditional stimulus, was followed by a 2 sec-
ond foot shock (0.3 mA), the unconditional stimulus.
After the shock, mice were allowed to explore once more
for 1 minute before they received a second conditional–
unconditional stimulus pairing. Finally, they were allowed
to explore for another minute. Twenty-four hours later, on
the third and last day, the animals were placed in the same
context for 5 minutes exploration (contextual fear assess-
ment). After 90 minutes, the mouse was again placed in
the test chamber. Environmental and contextual cues were
changed: a white plate was placed on the grid, light was
switched on and minute extract was used to alter the
smell. After 3 minutes of free exploration (pre-cue phase),
the auditory stimulus was delivered for 3 minutes (cued
fear assessment). Freezing behavior was recorded every
10 seconds during each trial block using the standard
interval sampling procedure.
Antibodies
Goat-Alexa Fluor® 488 and 594 conjugated anti-mouse
or anti-rabbit secondary antibodies were used (Molecu-
lar Probes, Eugene, USA). Primary antibodies included
rat-anti-CD68 (Serotec, Edinburgh, UK), rabbit-anti-actin,
mouse-anti-GFAP, mouse-anti-MAP-2 (Sigma Aldrich,
Steinheim, Germany), mouse-anti-huntingtin (Millipore,
Schwalbach, Germany), rabbit-anti-LC3 and rabbit-anti-
p62 (Enzo Life Sciences, Lörrach, Germany), rat-anti-
LAMP-2 (Abl93) and rat-anti-LAMP-1 (1D4B) (DSHB,
Iowa City, US), rabbit-anti-LAMP-2A (Pineda, Berlin,
Germany), rabbit-anti-cathepsin D (a kind gift from Prof.
J. Aerts), mouse-anti-MEF2D (BD Biosciences (Heidelberg,
Germany), rabbit-anti-GAPDH and rabbit-anti-α-synuclein
(C-20) (Santa Cruz, Dallas, US), rabbit-anti-caspase-3,
rabbit-anti-phospho-PRAS40 and rabbit-anti-PRAS40 (Cell
Signalling, Frankfurt am Main, Germany) and rabbit-anti-
NSE (Abcam, Cambridge, UK).
SDS-PAGE, Immunoblotting, assays monitoring MA and
CMA substrate degradation and enzyme activity
For starvation assays, cells were extensively washed and
cultured for 3 or 24 hours in Earl’s Balanced Salt Solu-
tion (EBSS) or Dulbecco's Modified Eagle's Medium
(DMEM) without serum, supplemented with antibiotics
before harvesting. Enzyme activity assays were performedon lysates from 54-week-old mice (n = 3 wild-type and
n = 3 LAMP-2-deficient) as previously described [33].
N2a cells and brain tissue were lysed in RIPA buffer and
denatured in Laemmli. For immunoblotting, protein
samples were loaded on an SDS gel and blotted on a
nitrocellulose or PVDF membrane (Roth, Karlsruhe,
Germany). Membranes were probed with the relevant pri-
mary and secondary antibodies. Peroxidase-conjugated
secondary antibodies were detected by chemiluminescence
(SuperSignalWest, Pierce, Pittsburgh, USA). Densitomet-
ric analyses were performed with Image J software (http://
imagej.nih.gov/ij/). Samples were normalized to the load-
ing control and are presented as protein levels relative to
wild-type or untreated, non-transfected samples where
appropriate.
Preparation and maintenance of primary neuronal and
astroglial culture
Primary neurons were prepared as described previously
[34] from the cortices of gestational day 15 embryos.
After 3 days, cultured cells were treated with 10 μM
cytosine arabinoside. Primary glial cultures were pre-
pared as above but cultured in minimum essential
medium with 10% horse serum and penicillin/strepto-
mycin. Cells were fixed in 4% paraformaldehyde diluted
in PBS after 14 days in vitro.
Relative quantitative RT-PCR
Messenger RNA was isolated from whole brain using
the NucleoSpin® RNAII kit (Macherey-Nagel, Düren,
Germany) according to the manufacturer’s instructions.
Complementary DNA was created using 2 μg total RNA
and amplified using oligodT primers and the RevertAid
cDNA synthesis Kit (Fermentas, St. Leon-Rot, Germany).
Negative controls (RT-) were carried out in the absence of
reverse transcriptase to check for genomic contamination.
Quantitative RT-PCR, using actin as the house-keeping
gene, was carried out using the Universal® probe library
and Lightcycler 480 II from Roche (Mannheim, Germany)
according to the manufacturer´s instructions. Relative
expression was calculated using an efficiency-corrected
comparative quantitation method [35]. To determine effi-
ciency of each primer set, a standard curve was plotted
using 10-fold serial dilutions of a mix of applied cDNA,
followed by a logarithmic conversion and a linear response
generated.
Statistical analysis
All values are expressed as the mean ± standard error of
the mean. Differences among mean values were analyzed
via a two-tailed, unpaired Student t-test using Microsoft
Excel software or one-way ANOVA followed by Tukey
post-Hoc test, using GraphPad Prism 5, where multiple
samples were compared. Behavioral data were analyzed
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Whitney Rank Sum Test or Repeated-Measures ANOVA
where appropriate. The null hypothesis was rejected at
p < 0.05.
Results
Loss of LAMP-2 expression causes neuropathological
changes in mice
Similarities in the pathological presentation of Danon
disease in cardiac and skeletal muscle of humans and
LAMP-2-deficient (LAMP-2-/y) mice [4,28] that were of
a mixed genetic background (SVJ-129/C57BL6-J (Harlan))
highlight the validity of this mouse as a model for the hu-
man disease. The neuropathological characterization of
LAMP-2-deficient mice was carried out in animals back-
crossed into C57/BL6-N (Charles River). We recently re-
ported that backcrossing of LIMP-2 (Lysosomal Integral
Membrane Protein type-2) knockout mice, that were
maintained within the same mixed genetic background
as the LAMP-2-deficient mice, into C57/BL6-N led to a
deterioration of their phenotype including accumulation
of α-syn, severe CNS impairments and premature death
[36]. In contrast, LAMP-2-deficient mice of the mixed
and C57/BL6-N background were macroscopically indis-
tinguishable from each other.
Histological analysis of the CNS of 12-month-old
LAMP-2-deficient mice revealed wide-spread astrogliosis
within all brain regions, including the hippocampus, as
illustrated by immunohistochemistry (Figure 1a) and im-
munoblotting (Figure 1b) with an antibody directed
against the Glial Fibrillary Acidic Protein (GFAP). Mild
microgliosis (Figure 1c and Additional file 1a), as depicted
by immunohistochemical staining using an antibody spe-
cific for the microglia resident protein macrosialin/CD68,
was observed throughout LAMP-2-deficient brains. In the
subiculum of the hippocampus and pons, microgliosis was
most prominent. Here, microglia assumed a morphology
indicative of their activation (Figure 1c, left and middle
panels). Toluidine blue stained sections of LAMP-2-
deficient brains, revealed darkly stained degenerating neu-
rons within the hippocampus, particularly the subiculum
and the CA3 region (Additional file 1b). However, no
indication of apoptosis was evident, as highlighted
by Terminal deoxynucleotidyl transferase dUTP Nick
End Labeling (TUNEL) (Additional file 1c) and lack
of caspase-3 cleavage (Additional file 1d). Using an anti-
body (Abl93, Development Studies Hybridoma Bank) that
recognizes all LAMP-2 isoforms (pan LAMP-2), LAMP-2
was shown to be expressed in both primary cultured neu-
rons (Figure 2a) and astrocytes (Figure 2b). Immunoblot
analysis of different brain regions, obtained from wild-type
mice, revealed ubiquitous expression of LAMP-2 within
the CNS. Quantification of LAMP-2 immunoblot levels
relative to cortex revealed the highest expression ofLAMP-2 in the cerebellum and the lowest in the hippo-
campus (Figure 2c). Expression of both LAMP-2A
and LAMP-2B isoforms in the hippocampus was
also evident by quantitative (q) RT-PCR (Figure 2d/e).
LAMP-2A appeared to be the most abundant isoform
expressed in brain (Figure 2d) whereas transcripts
of LAMP-2C, an isoform implicated in the uptake of
RNA and DNA [37] was not detectable in brain using
semi-quantitative PCR (data not shown). Immunohisto-
chemistry of brain sections showed localized enriched
expression of LAMP-2 in neurons especially in pyram-
idal neurons of the hippocampus (Figure 2f, upper
panels and Additional file 2a, upper panels) and in the
pons (Figure 2f, middle panels and Additional file 2a,
lower panels). Despite its similar distribution, we did
not observe a compensatory upregulation of LAMP-1 in
LAMP-2-deficient brain as illustrated by LAMP-1 im-
munoblot (Additional file 2b) and immunohistological
(Additional file 2c) analysis. From our data we conclude
that LAMP-2 is an abundant protein of neuronal tissue
and that loss of its expression causes neuroinflamma-
tion in mice.
Behavioral anomalies as a result of LAMP-2 deficiency
Danon disease patients present with neurological mani-
festations in the form of intellectual dysfunction [25-27].
LAMP-2-deficient mice were subjected to a battery of
behavioral tests that included measures of motor per-
formance (gait analysis, grip strength, activity, rotarod
and swim test) and exploration as well as indices of
learning and memory (Y-maze, contextual fear condi-
tioning). Gross motor behavior appeared unaltered in
LAMP-2-deficient mice, as there were no significant dif-
ferences when compared to wild-type controls in grip
strength, rotarod performance and home cage activity
(Additional file 3a-c). Likewise, rudimentary gait param-
eters such as base-widths and stride lengths were similar
between genotypes (data not shown). However, max-
imal paw area was reduced in LAMP-2-deficient mice
(Figure 3a). Although this might indicate altered plantar
placing in the context of a motor deficit, it is more likely a
consequence of reduced body weight in these mice (data
not shown). Impaired motor performance of LAMP-2-
deficient mice was evident in the swim test exemplified by
severely reduced swimming velocity (Figure 3b). This ef-
fect was not confirmed to be caused by muscular weak-
ness as grip strength performance was normal. Reduced
exploratory activity was observed in the exploration test
(Figure 3c). Considering unaltered levels of home cage ac-
tivity (Additional file 3c), this effect does not appear to re-
flect general hypolocomotion of LAMP-2-deficient mice.
Rather, it could indicate blunted affective response to the
novel environment. LAMP-2-deficient mice show an in-
creased freezing percentage during the habituation phase
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may be the consequence of reduced exploratory move-
ment. However, fear conditioning as well as contextual
and cued fear memory was intact in LAMP-2-deficient
mice (Figure 3d). In the Y-maze task, LAMP-2-deficient
mice made relatively less alternations (Figure 3e) in com-
parison with wild-type control mice, indicating impaired
working memory. In conclusion, LAMP-2-deficient mice
show particular motor impairments, reduced exploratoryactivity and signs of impaired memory, consistent with
hippocampal dysfunction.
Lysosomal dysfunction in hippocampal neurons
The presence of neuroinflammation and behavioral
anomalies in mice lacking LAMP-2 expression highlights
the importance of this lysosomal protein in brain. To as-
sess whether loss of LAMP-2 leads to lysosomal dysfunc-
tion that correlates with the observed neuropathological
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specificity of the LAMP-2 antibody; actin was used as a loading control; *p < 0.05, **p < 0.01, ***p < 0.001). Quantitative RT-PCR of isoforms (d) LAMP-2A
and (e) LAMP-2B in respective brain regions. (f) Representative histological brain sections stained for LAMP-2 using the DAB method and counterstained
with Nissl. No signal was detected in LAMP-2-/y brains. Enriched expression was observed in the pyramidal layer of the hippocampus, within the Purkinje
cell layer of the cerebellum and within a region of the pons. Insets show zoomed images of regions outlined.
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somal hydrolases β-hexosaminidase and β-glucuronidase
as well as the maturation of cathepsin D as a means
of evaluating lysosomal function. Whereas a significantincrease of all forms of cathepsin D (pro (p), immature (i)
and mature (m)) was observed in the hippocampus and in
the cortex (Figure 4a, Additional file 4), no marked change
in the maturation of the enzyme was detected (Figure 4a).
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mice displayed a significant increase in β-hexosaminidase
(Figure 4b) and β-glucuronidase (Figure 4c) activity
whereas in the pons and cerebellum only β-hexosaminidase
activity was elevated. In summary, among all other brain
regions investigated, the hippocampus of LAMP-2-
deficient mice showed the most consistent signs of alter-
ations in lysosomal enzyme activity.
Lipid storage and autophagic vacuoles in LAMP-2-deficient
hippocampal neurons
Degradation of long-lived proteins which has been shown
to be impaired in LAMP-2-deficient hepatocytes [4]
mainly occurs by autophagy [38]. The detection of in-
creased levels of proteins that are pivotal for the autopha-
gic flow and are degraded in the lysosome, such as the
adaptor protein sequestosome 1 (SQSTM1/p62) [39,40], is
widely used as an indication of impaired autophagy. Im-
munohistochemical analysis of LAMP-2-deficient brain
revealed a distinct accumulation of p62-positive aggregates
specifically within the subiculum and CA1 region of the
hippocampus and the pons (Figure 5a).Periodic-Acid-Schiff (PAS) staining identified carbohy-
drate-conjugates within the brain of one Danon disease
patient [29]. In neuronal tissues of LAMP-2-deficient
mice, no apparent PAS-positive storage was evident
(Additional file 5a). Filipin staining displayed storage of
free cholesterol exclusively in the subiculum of LAMP-2-
deficient mice (Figure 5b). High power electron micro-
graphs revealed the presence of Lipid Whorls (LW) that
are implicated in lysosomal storage disease and choles-
terol accumulation [41] in degenerating neurons within
the CA3 and subiculum of LAMP-2-deficient mice
(Figure 5c, upper left and lower right panels). Additionally,
Lipofuscin (L) and Autophagic Vacuoles (AVs) containing
amorphous or multilamellar material were evident within
dystrophic neurites and axonal spheroids in the hippo-
campus (Figure 5c) which were not present in control
mice (Additional file 5b). Storage of AVs within axons led
to disruption of the presynaptic terminal highlighted by
complete absence of synaptic vesicles (Figure 5c, bottom
left panel). Storage was observed both within the soma
and neurites of cells. Our histological data indicate that
loss of LAMP-2 expression causes lysosomal/autophagic
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However, in hippocampal extracts that were prepared
from LAMP-2 knockout mice we found no significantly
increased levels of LC3-II or p62 (Additional file 5c). The
ratio of phosphorylated proline-rich Akt substrate 40
(PRAS40) which is known to negatively regulate autoph-
agy [42,43] was also not changed in LAMP-2-deficient
samples (Additional file 5c, middle panel) indicating no
overall increase in basal MA when LAMP-2 is absent.
Proteasomal activity was also unaltered since levels of
poly-ubiquitinated proteins were unchanged in LAMP-2
knockout brain samples when compared to wild-type
controls (data not shown).
Loss of LAMP-2 does not influence the steady-state levels
of CMA substrates and is dispensable for starvation
induced clearance of these proteins
LAMP-2A is reported to be the rate-limiting factor in
CMA [14,15]. Such proteins that are degraded via CMA
include those associated with neurodegenerative diseases
such as MEF2D, Htt as well as the glycolytic enzyme
GAPDH [15]. Thus, we assessed a potential accumula-
tion of these substrates, due to the lack of the CMA re-
ceptor LAMP-2A, through analysis of brain lysates from
knockout animals as well as in vitro after stable knock-
down of LAMP-2 in murine neuroblastoma cells (N2a).
Absence of LAMP-2 expression in cortex and hippo-
campus (Figure 6a) did not affect the steady-state levels
of MEF2D (Figure 6b), GAPDH (Figure 6c) or Htt(Figure 6d, Additional file 6a). Expression levels of Htt
were also found to be unchanged in striatum (Figure 6d)
which is the primary site of neuronal damage in Hun-
tington`s disease. Similarly, stable knockdown of LAMP-
2 in N2a cells using shRNA directed against LAMP-2
mRNA significantly reduced protein levels of LAMP-2
(Figure 6e) but not LAMP-1 (Additional file 6b) and did
not alter steady-state levels of MEF2D (Figure 6f ),
GAPDH (Figure 6g) or Htt (Figure 6h). Furthermore, an
accumulation of MEF2D within the cytosol, which has
been reported after blockage of CMA by LAMP-2 silen-
cing [44], was not revealed neither in LAMP-2-deficient
primary neurons (Additional file 6c) nor in brain sec-
tions (Additional file 6d). The typical nuclear localization
of this protein was observed independent of the expres-
sion of LAMP-2.
Prolonged starvation of cells for 24 hours in serum-free
media is known to induce CMA [45]. In order to investi-
gate LAMP-2-dependent clearance of substrates after ex-
tended starvation, N2a cells, stably transfected with either
LAMP-2 shRNA or scramble (control) shRNA, were cul-
tured in nutrient free (without serum and amino acids)
Earl`s Balanced Salt Solution (EBSS) or in Dulbecco`s
Modified Eagle Medium (DMEM) devoid of serum for
24 hours. Both starvation treatments did not affect the
viability of cells as judged by visual inspection and im-
munoblotting of cleaved caspase-3 (data not shown).
Since prolonged starvation under nutrient free conditions
induces expression and nuclear translocation of the
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late lysosomal biogenesis [46], we have assessed protein
levels of LAMP-2A, LAMP-2B, LAMP-1 and LIMP-2 via
immunoblotting and qRT-PCR analysis. In order to spe-
cifically detect LAMP-2A we have used a self-made anti-
body that only recognizes LAMP-2A as highlighted byimmunoblots of HeLa cell extracts overexpressing the
three different LAMP-2 isoforms (LAMP-2A, B and C)
as well as LAMP-1. Furthermore, no signal was detect-
able in LAMP-2-deficient brains, confirming the specifi-
city of this antibody (Additional file 7a). Serum removal
for 24 hours decreased steady-state levels of MEF2D,
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Figure 6 Analysis of steady-state levels of CMA substrates in brain. (a-d) Immunoblots and respective densitometry of lysed hippocampi/
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(Htt) (d). (e-h) Immunoblots and respective densitometry of lysates from N2a cells either non-transfected (non) or stably transfected with scramble
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file 7b). Prolonged starvation in complete nutrient-free
medium also led to a pronounced decline of MEF2D
levels as well as GAPDH (Figure 7a) independent of
LAMP-2 expression (Figure 7b). Messenger RNA levels
of GAPDH and MEF2D were equal in control and
LAMP-2 shRNA starved samples (Additional file 7c).
Under these conditions we observed a significant in-
crease in LAMP-2A expression in control cells as shown
by immunoblotting (Figure 7b) and qRT-PCR (Figure 7c).
Interestingly, an increase was also observed in LAMP-
2B (Figure 7c) as well as two other lysosomal membrane
proteins investigated namely LAMP-1 (Figure 7d/e) and
LIMP-2 (Figure 7f/g).
The knockdown of LAMP-2 did not alter basal
(Additional file 7d) or induced MA (Additional file 7e) asindicated by unchanged levels of phosphorylated PRAS40,
p62 and LC3-II in control and LAMP-2 shRNA treated
N2a cells. Successful induction of MA was monitored by a
decline in p62 levels and reduced phosphorylation of
PRAS40 (Additional file 7e). Finally, despite the fact that
down-regulation of LAMP-2 was reported to lead to
an accumulation of another CMA substrate, α-syn in
cultured neuronal cells [19,47], complete loss of LAMP-2
expression in murine brain did not cause a significant
accumulation of either monomeric or high-molecular
weight species of α-syn within the cortex or hippocampus
(Figure 8a/b).
Though prolonged starvation significantly increased
LAMP-2A levels in N2a cells, this is not unique to this
isoform since a comparable upregulation was also evi-
dent for LAMP-2B, LAMP-1 and LIMP-2. Furthermore,
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in brain tissue and in neuroblastoma cells.
Discussion
The current report highlights LAMP-2 as a ubiquitously
expressed protein of the CNS. In addition to its estab-
lished role as a receptor for CMA, the function of
LAMP-2 in the brain is not yet well defined. Absence of
LAMP-2 in brain, especially within the subiculum and
CA3 region of the hippocampus, caused pronounced in-
flammation as well as perturbed lysosomal activity and
autophagy indicated by intraneuronal lipid storage, accu-
mulation of autophagic vacuoles and neuronal degen-
eration in a subpopulation of neurons. Hippocampal
neurons are particularly vulnerable to lysosomal stor-
age induced degeneration as highlighted in various
mouse models with lysosomal dysfunction [48,49] and
in Alzheimer and Parkinson`s disease as well as dementia
with Lewy bodies. To some extent this vulnerability can
be explained by regional differences in the expressionprofile of proteins that can induce neurotoxicity under
certain pathophysiological conditions such as aggregation
of α-syn and amyloid-β. Interestingly, hippocampal but
not cortical motor neurons were described as vulnerable
to ischemia/reactive oxygen species-induced neurotoxicity
through calpain-mediated cleavage of carbonylated hsp70
[50] thereby diminishing its neuroprotective effect [51,52].
A reduction in LAMP-2 expression has been directly
linked to low CMA activity as well as increased levels of
oxidized proteins in aged livers [15,45] and breast cancer
cells [53]. It is therefore tempting to speculate that loss of
LAMP-2, especially within hippocampal neurons, leads to
an accumulation of oxidized proteins that may contribute to
the observed neuropathology. Further studies are necessary
in order to elucidate the impact of oxidative stress as a
potential cause of CMA blockage on the neuropathology of
LAMP-2-deficient mice.
Our data suggest a distinct role of LAMP-2 within the
hippocampus that might be causative for the observed
intellectual dysfunction in Danon disease patients
Rothaug et al. Acta Neuropathologica Communications  (2015) 3:6 Page 14 of 17[25,26,54,55]. Besides the development of a mild astro-
gliosis, no other neuropathological changes within the
hippocampus were described within the brain of one
Danon disease patient [29]. Therefore, the hippocampus
should be of special interest when examining brain aut-
opsy material from Danon disease patients in the future.
It should also be noted that according to our analyses,
LAMP-2A is the most prominent isoform in brain
whereas LAMP-2B was only present to a minor degree
and LAMP-2C was undetectable under the experimental
conditions used. This is in contrast to the described
prominent expression of LAMP-2C in murine brain
[37]. Therefore, further analysis is necessary in order to
elucidate the expression and relative abundance of the
different LAMP-2 isoforms in brain.
Due to the rarity of the disease and the limited access
to autopsy brain material, LAMP-2-deficient mice pro-
vide an important tool in studying the molecular mecha-
nisms underlying Danon disease neuropathology. We
observed behavioral changes in these mice which relate
to neuromuscular and intellectual dysfunction in patients.
Likewise, the neuropathology of LAMP-2-deficient mice
and Danon disease patients share common characteristics.
Both show pronounced inflammation exemplified by an
increased expression of GFAP in activated astrocytes des-
pite absence of obvious signs of pronounced neurodegen-
eration [29]. Interestingly, GFAP was identified as a
modulator of CMA that stabilizes the multimeric CMA
translocation complex formed within the lysosomal mem-
brane after CMA induction [56]. Absence of LAMP-2
may interfere with formation of such a complex ultimately
leading to the activation of astrocytes.
In addition to inflammation, another prominent fea-
ture of the neuropathology described for one Danon
disease patient is the presence of electron dense bodies
and lipofuscin-rich deposits throughout the brain [29].
In mice, among all other brain regions investigated, the
hippocampus displayed most prominent signs of storage
especially in the subiculum in which neuronal accumula-
tion of free cholesterol and lipofuscin was evident. Previ-
ously, we reported cholesterol storage in LAMP-2-deficient
liver [10]. This phenotype was mirrored in murine
embryonic fibroblasts lacking LAMP-2 and to a higher
extent in cells in which both LAMP proteins were
deleted [9,10]. Rescue experiments of the observed
cholesterol storage by re-expressing both LAMPs into
LAMP-1/LAMP-2-double-deficient fibroblasts suggest
a distinct role of LAMP-2 but not LAMP-1 in choles-
terol metabolism. However, this effect was not isoform
specific since all three LAMP-2 variants were equally effect-
ive in abolishing the late endosomal/lysosomal cholesterol
accumulation [10]. Until now, the precise role of LAMP-2
within this process remains unknown and further analysis
is necessary in order to clarify how its expression influenceslipid and cholesterol metabolism, especially within neuronal
cells.
The pathological hallmark of Danon disease, which
was classified as a glycogen storage disorder [25,57], is
the presence of accumulated glycogen and autophagic
vacuoles within liver and muscle of patients and the
mouse model [4,26,58]. Therefore, LAMP-2 was sug-
gested to play an important role in the clearance of
glycogen and maturation of autophagic vacuoles [5,59].
Interestingly, the glycogen storage disorders Lafora and
Pompe disease, caused by mutations within enzymes
directly or indirectly involved in glycogen metabolism
[57], result in pronounced impairment of autophagy
in tissues that accumulated glycogen, including the CNS
[60-63]. Therefore, absence of accumulated glycogen
within brain samples of LAMP-2-deficient mice may
explain the lack of gross abnormalities in neuronal
autophagy and suggest a distinct function of LAMP-2 within
the hippocampus for autophagic clearance of neuronal
proteins.
The most well defined role for LAMP-2A is its func-
tion as a receptor for CMA, mediating the lysosomal up-
take of selective substrates such as MEF2D [44], Htt
[22,64,65], α-syn [47] and GAPDH [15]. In our hands,
despite apparent unaltered levels of MA and no change
in proteasomal activity, loss of LAMP-2 expression did
not affect steady-state levels of these proteins in brain ly-
sates or N2a cells under normal conditions. A compen-
satory upregulation of MA and proteasomal activity that
has been found upon blockage of CMA by silencing
LAMP-2 expression [66] is therefore unlikely to account
for the unchanged levels of CMA substrates in LAMP-
2-deficient brain. Of note, we also did not observe cyto-
solic accumulation of MEF2D which has been reported
as consequence of CMA blockage by knock-down of
LAMP-2 expression [44]. In our hands, neither complete
absence nor down-regulation of LAMP-2 affected the
typical nuclear localization of this protein further sug-
gesting that LAMP-2 is dispensable for clearance of
CMA substrates under the investigated conditions. How-
ever, lysosomal uptake experiments of selected CMA
substrates would help to clarify the impact of LAMP-2
deficiency within this pathway under normal and stress
induced conditions.
With regard to the unchanged levels of α-syn in
LAMP-2 knockout brains it is interesting to note that
elevated expression of α-syn in the C57/BL6-N genetic
background led to a deterioration of the phenotype of
LIMP-2-deficient mice [36]. In contrast, absence of
LAMP-2 within the same genetic background did not
affect α-syn levels suggesting that LAMP-2 is dispens-
able for its clearance. This correlates with previous stud-
ies where double deficiency of LAMP-1 and 2 in mouse
embryonic fibroblasts did not affect CMA-mediated
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or mechanisms for CMA besides LAMP-2A [9,67].
CMA can be induced indirectly by various stimuli
such as prolonged starvation or directly by overexpres-
sion of its receptor LAMP-2A [68]. Htt, MEF2D,
GAPDH and α-syn levels were shown by others to be
directly linked to expression of LAMP-2A [19,20,44,47].
However, in N2a cells, similar to the situation in LAMP-
2-deficient brains, a reduction in LAMP-2 expression
did not affect steady-state levels of CMA substrates even
after prolonged incubation in nutrient or serum-free
medium. Furthermore, in control cells, prolonged star-
vation did not specifically elevate LAMP-2A levels but
led to a general increase in lysosomal membrane protein
expression namely LAMP-2B, LAMP-1 and LIMP-2.
Interestingly, this is in agreement with reports where an
increase in LAMP-2A but also LAMP-1 expression was
reported after prolonged starvation [15]. Our results are
in agreement with the described effect of prolonged star-
vation that stimulates TFEB induced lysosomal biogen-
esis and degradation by increasing the expression of
lysosomal membrane proteins and hydrolases [46,69].
However, further analysis will aid in the interpretation of
the role of TFEB in starvation-induced CMA and its ef-
fect on expression levels, specifically of LAMP-2A.
Conclusion
In conclusion, our data suggest a novel role of LAMP-2
for lysosomal and autophagic clearance within hippo-
campal neurons and contribute to the understanding of
neuropathology in Danon disease.
Additional files
Additional file 1: Neuropathology of LAMP-2-deficient mice.
Representative histological brain sections from LAMP-2-deficient (LAMP-2-/y)
mice and their wild-type (WT) littermates. (a) Microgliosis observed in
LAMP-2-/y animals via CD68 immunological staining (insets depict zoomed
images of outlined area, sections were costained with Nissl). Representative
histological sections stained with (b) toluidine blue (arrows highlight
shrunken cells) and (c) TUNEL (sections were costained with the nuclear
stain haematoxylin). (d) Immunoblot of caspase-3 from hippocampal lysates
(FL, full length, p17 and p20 refer to caspase-3 cleavage products; NSE was
used to control loading).
Additional file 2: No change in LAMP-1 expression in absence of
LAMP-2 within brain. (a) Representative histological brain sections
stained for LAMP-2 using the DAB method and counterstained with Nissl.
No signal was detected in LAMP-2-deficient (LAMP-2-/y) brains. Enriched
expression was observed in an area of the pons. (b) Immunoblots of
lysates from wildtype (WT) and LAMP-2-/y brains probed for LAMP-1 and
respective densitometric quantification (actin was used to control loading).
(c) Representative histological brain sections stained for LAMP-1 using the
DAB method and counterstained with Nissl. Enriched expression was
observed in the pyramidal layer of the hippocampus, within the Purkinje cell
layer of the cerebellum and within a region of the pons. Zoomed imaged of
regions outlined are shown underneath pictures of the hippocampus/pons
(#p>0.05).
Additional file 3: Behavioral analyses of mice at 54 weeks. (a) LAMP-2-
deficient (LAMP-2-/y) mice showed similar grip strength when compared towild-type controls. (b) No significant difference in performance using a
rotarod was observed between wild-type and LAMP-2-/y mice. (c) No
differences in cage activity were observed between wild-type and LAMP-2-/y
mice.
Additional file 4: Cathepsin D levels in brain. Densitometric analysis
of cathepsin D (CtD) levels corresponding to representative blots in
Figure 4 (#p>0.05, *p<0.05, **p<0.01).
Additional file 5: Absence of carbohydrate storage or perturbed
autophagy in LAMP-2-deficient brain. (a) Representative histological
sections from LAMP-2-deficient (LAMP-2-/y) mice and their wild-type (WT)
littermates stained with Periodic-Acid-Schiff (PAS). Sections were cost-
ained with the nuclear stain haematoxylin. (b) Electron micrograph show-
ing normal morphology within the subiculum of a WT animal.
(c) Immunoblots and respective densitometric quantification of hippocampal
lysates.
Additional file 6: Lack of LAMP-2 expression does not affect LAMP-1
levels and has no effect on huntingtin or MEF2D. (a) Immunoblot of
hippocampal lysates from LAMP-2-deficient (LAMP-2-/y) mice and their
wild-type (WT) littermates. (b) Immunoblots of lysates from N2a cells either
non-transfected (non) or stably transfected with scramble shRNA (Scmbl) or
shRNA targeting LAMP-2 mRNA showing protein levels of LAMP-1. The
specificity of the applied shRNA LAMP-2 probe is highlighted by unchanged
levels of LAMP-1 protein (actin was used to control loading).
(c) Immunofluorescence of MEF2D (red) and LAMP-2 (green) in primary
neurons. (d) Immunofluorescence of MEF2D (red) in hippocampal slices
(Dapi (4',6-diamidino-2-phenylindole) was used as a nuclear stain, insets
shown zoomed images of area outlined).
Additional file 7: Stable knockdown of LAMP-2 has no effect on
expression of MEF2D or GAPDH in N2a cells. (a) Immunoblot of
lysates from brain lysates from wild-type (WT) and LAMP-2-deficient
(LAMP-2-/y) mice as well as HeLa cells overexpressing eGFP, murine
LAMP-1 (L1), murine LAMP-2A (L2A), murine LAMP-2B (L2B) or murine
LAMP-2C (L2C). The LAMP-2A antibody used in this study is specific for
the murine isoform A (actin was used to control loading and LAMP-1 to
control for specificity). (b) Immunoblots and respective quanticiation from
N2a cells either non-transfected (non) or stably transfected with scramble
shRNA (scmbl) or shRNA targeting LAMP-2 mRNA. MEF2D levels decrease after
starvation in serum-free DMEM. (c) Quantitative RT-PCR of samples from N2a
cells either non-transfected (non) or stably transfected with scmbl shRNA or
shRNA targeting LAMP-2 mRNA. MEF2D expression increases after starvation
of the cells. However, no significant differences were observed
between scmbl and LAMP-2 shRNA treated samples. GAPDH expression
remained constant in all samples (#p>0.05, ***p<0.001). (d) Immunoblot
and respective quantification from N2a cells showing lack of changes in
macroautophagy upon knockdown of LAMP-2 (p-PRAS40 refers to
phosphorylated-PRAS40; actin was used to control loading). (e) Immunoblots
and respective densitometric quantification of lysates from N2a cells either
untreated or starved for 3 hours to induce macroautophagy.Abbreviations
CMA: Chaperone-mediated autophagy; Htt: Huntingtin; α-syn: α-synuclein;
MEF2D: Myocyte-specific enhancer factor-2D; GAPDH: Glyceraldehyde-3-
phosphate dehydrogenase; LAMP-2: Lysosomal associated membrane
protein type-2; MA: Macroautophagy.Competing interests
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